Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 4
2019 5
2020 4
2021 2
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.
Fernández-Bargiela N, Rotea-Salvo S, Margusino-Framiñán L, Balboa-Barreiro V, Martín-Herranz I, Castro-Iglesias Á, Mena-De-Cea Á, López-Calvo S, Vázquez-Rodríguez P, Míguez-Rey E, Cid-Silva P. Fernández-Bargiela N, et al. Among authors: cid silva p. Eur J Hosp Pharm. 2022 Jul;29(4):207-211. doi: 10.1136/ejhpharm-2020-002374. Epub 2020 Oct 13. Eur J Hosp Pharm. 2022. PMID: 33051194 Free PMC article.
Lipid profile changes associated with antiretroviral therapies in a real-world cohort.
Rotea-Salvo S, Giménez-Arufe V, Martínez-Pradeda A, Fernández-Oliveira C, Mena-de-Cea Á, Margusino-Framiñán L, Martín-Herranz I, Cid-Silva P. Rotea-Salvo S, et al. Among authors: cid silva p. Farm Hosp. 2023 Sep-Oct;47(5):210-217. doi: 10.1016/j.farma.2023.04.007. Epub 2023 Jun 20. Farm Hosp. 2023. PMID: 37349200 Free article. English, Spanish.
Lipid profile changes associated with antiretroviral therapies in a real-world cohort.
Rotea-Salvo S, Giménez-Arufe V, Martínez-Pradeda A, Fernández-Oliveira C, Mena-de-Cea Á, Margusino-Framiñán L, Martín-Herranz I, Cid-Silva P. Rotea-Salvo S, et al. Among authors: cid silva p. Farm Hosp. 2023 Sep-Oct;47(5):T210-T217. doi: 10.1016/j.farma.2023.07.005. Epub 2023 Sep 5. Farm Hosp. 2023. PMID: 37673703 Free article. English, Spanish.
Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward.
Martínez Pradeda A, Albiñana Pérez MS, Fernández Oliveira C, Díaz Lamas A, Rey Abalo M, Margusino Framiñan L, Cid Silva P, Martín Herranz MI. Martínez Pradeda A, et al. Among authors: cid silva p. Farm Hosp. 2023 May-Jun;47(3):T121-T126. doi: 10.1016/j.farma.2023.05.003. Epub 2023 May 26. Farm Hosp. 2023. PMID: 37246122 Free article. English, Spanish.
Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward.
Martínez Pradeda A, Albiñana Pérez MS, Fernández Oliveira C, Díaz Lamas A, Rey Abalo M, Margusino-Framiñan L, Cid Silva P, Martín Herranz MI. Martínez Pradeda A, et al. Among authors: cid silva p. Farm Hosp. 2023 May-Jun;47(3):121-126. doi: 10.1016/j.farma.2023.02.005. Epub 2023 Apr 18. Farm Hosp. 2023. PMID: 37059685 Free article. English, Spanish.
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.
Rotea-Salvo S, Martínez-Pradeda A, Fernández-Oliveira C, Giménez-Arufe V, Balboa-Barreiro V, Margusino-Framiñán L, Mena-De-Cea Á, Vázquez-Rodríguez P, Castro-Iglesias Á, López-Calvo S, Martín-Herranz I, Míguez-Rey E, Cid-Silva P. Rotea-Salvo S, et al. Among authors: cid silva p. Eur J Hosp Pharm. 2023 Jul;30(4):221-226. doi: 10.1136/ejhpharm-2021-002896. Epub 2021 Oct 14. Eur J Hosp Pharm. 2023. PMID: 34649965
Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice.
Margusino-Framiñán L, Bobadilla-Pérez E, Cid-Silva P, Rodríguez-Sotelo A, Yáñez-Rubal JC, Mena-de-Cea Á, Suárez-López F, Prieto-Pérez A, Giménez-Arufe V, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Among authors: cid silva p. J Med Virol. 2020 Dec;92(12):3488-3498. doi: 10.1002/jmv.25772. Epub 2020 Mar 28. J Med Virol. 2020. PMID: 32181917
Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.
Margusino-Framiñán L, Cid-Silva P, Rotea-Salvo S, Mena-de-Cea Á, Suárez-López F, Vázquez-Rodríguez P, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Among authors: cid silva p. Eur J Hosp Pharm. 2020 Mar;27(e1):e41-e47. doi: 10.1136/ejhpharm-2019-002060. Epub 2020 Feb 7. Eur J Hosp Pharm. 2020. PMID: 32296504 Free PMC article.
Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus.
Margusino-Framiñán L, Cid-Silva P, Giménez-Arufe V, Mondelo-García C, Fernández-Oliveira C, Mena-de-Cea Á, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Among authors: cid silva p. Eur J Hosp Pharm. 2021 Jan;28(1):16-21. doi: 10.1136/ejhpharm-2019-001889. Epub 2019 Jun 13. Eur J Hosp Pharm. 2021. PMID: 33355279 Free PMC article.
20 results